Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzoparib in Metastatic Non-clear Cell Renal Cell Carcinoma
NCT04535687Phase 2Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Dec 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluzoparib in non-clear cell renal cell carcinoma (nccRCC), sponsored by Nanjing Drum-Tower Hospital. Started Dec 2020; status: completed.
02
Drugs
fluzoparib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT04535687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04535687.